Medtronic logo

MedtronicNYSE: MDT

Profile

Sector:

Healthcare

Country:

Ireland

IPO:

02 May 1973

Next earnings report:

19 November 2024

Last dividends:

27 September 2024

Next dividends:

N/A
$116.76 B
-29%vs. 3y high
99%vs. sector
-13%vs. 3y high
51%vs. sector
-23%vs. 3y high
63%vs. sector
-31%vs. 3y high
52%vs. sector

Price

after hours | 26 min ago
$91.03+$1.79(+2.01%)
$7.92 B$8.27 B
$7.92 B$1.04 B

Analysts recommendations

Institutional Ownership

MDT Latest News

Medtronic (MDT) Outperforms Broader Market: What You Need to Know
zacks.com01 November 2024 Sentiment: -

Medtronic (MDT) reachead $90.07 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.

Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note
zacks.com28 October 2024 Sentiment: NEUTRAL

In the latest trading session, Medtronic (MDT) finished at $90.60, showing a slight increase of 0.01% compared to the day before.

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years
prnewswire.com28 October 2024 Sentiment: POSITIVE

The company is dedicated to improving clinical data for Symplicity™ through the SPYRAL Gemini clinical trial and the expansion of the GSR-DEFINE clinical trial. Medtronic plc recently shared long-term results from its SPYRAL HTN-ON MED clinical trial, which indicated that patients who received radiofrequency renal denervation with the Symplicity™ Spyral system experienced significantly lower blood pressure after two years compared to those who did not receive the treatment. This information was presented at the 2024 Transcatheter Cardiovascular Therapeutics Conference (TCT).

A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
prnewswire.com24 October 2024 Sentiment: POSITIVE

Medtronic has received FDA approval for its innovative Affera™ Mapping and Ablation System, which includes the Sphere-9™ Catheter. This all-in-one device combines high-density mapping with pulsed field and radiofrequency ablation to treat persistent atrial fibrillation and certain types of atrial flutter. With this approval, Medtronic is the first company to offer two pulsed field ablation technologies for patients with atrial fibrillation.

MDT vs. ABT: Which Stock Is the Better Value Option?
zacks.com21 October 2024 Sentiment: POSITIVE

Investors interested in the Medical - Products sector may want to look at Medtronic (MDT) or Abbott (ABT). However, which of these companies is the better choice for those seeking undervalued stocks?

Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
zacks.com11 October 2024 Sentiment: POSITIVE

In the most recent trading session, Medtronic (MDT) finished at $89.36, which is an increase of 0.57% compared to the day before.

Medtronic: Undervalued Dividend Aristocrat With High Margins
seekingalpha.com10 October 2024 Sentiment: POSITIVE

Medtronic is still a good investment choice because it has various sources of income, a strong range of products, and better profit margins. The company's growth comes from its success in Neuroscience, Cardiovascular, and Diabetes care, along with notable revenue growth from international markets and a hopeful product lineup. With its current trading price lower than its past value, MDT presents a great chance for cautious investors looking for quality at a fair price.

MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
zacks.com09 October 2024 Sentiment: POSITIVE

The recent interest rate reduction is expected to assist Medtronic in growing its presence in the AFib, structural heart, robotics, neuromodulation, hypertension, and diabetes sectors.

The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International
zacks.com09 October 2024 Sentiment: NEUTRAL

This Analyst Blog features companies like JPMorgan, Medtronic, Shopify, and Perma-Pipe International.

Medtronic (MDT) Advances But Underperforms Market: Key Facts
zacks.com04 October 2024 Sentiment: POSITIVE

Medtronic (MDT) finished the last trading session at $88.26, which represents a 0.56% increase from the previous day's closing price.

What type of business is Medtronic?

Medtronic plc is a global leader in the development and manufacturing of medical equipment for therapeutic and diagnostic purposes. The company's strategy is based on the application of biomedical engineering in research, development, and production of devices to alleviate pain, restore health, and prolong life. The company was founded in 1949. The main executive office is located in Dublin, Ireland. Research and manufacturing centers are located in the United States, China, Ireland, the Dominican Republic, Switzerland, and Israel. Today, Medtronic plc's medical equipment is installed in healthcare facilities, preventive institutions, and outpatient centers in more than 150 countries worldwide. A significant portion of the company's trade receivables is accounted for by national healthcare systems in these countries.

What sector is Medtronic in?

Medtronic is in the Healthcare sector

What industry is Medtronic in?

Medtronic is in the Medical Devices industry

What country is Medtronic from?

Medtronic is headquartered in Ireland

When did Medtronic go public?

Medtronic initial public offering (IPO) was on 02 May 1973

What is Medtronic website?

https://www.medtronic.com

Is Medtronic in the S&P 500?

Yes, Medtronic is included in the S&P 500 index

Is Medtronic in the NASDAQ 100?

No, Medtronic is not included in the NASDAQ 100 index

Is Medtronic in the Dow Jones?

No, Medtronic is not included in the Dow Jones index

When was Medtronic the previous earnings report?

No data

When does Medtronic earnings report?

The next expected earnings date for Medtronic is 19 November 2024